NeueHealth, Inc. (NEUE)
NYSE: NEUE · Real-Time Price · USD
5.85
+0.25 (4.45%)
Oct 11, 2024, 3:55 PM EDT - Market closed
NeueHealth Revenue
NeueHealth had revenue of $225.99M in the quarter ending June 30, 2024, a decrease of -24.16%. This brings the company's revenue in the last twelve months to $1.03B, up 1.35% year-over-year. In the year 2023, NeueHealth had annual revenue of $1.16B with 54.53% growth.
Revenue (ttm)
$1.03B
Revenue Growth
+1.35%
P/S Ratio
0.05
Revenue / Employee
$825,364
Employees
1,252
Market Cap
48.25M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
P3 Health Partners | 1.40B |
Inotiv | 501.06M |
SHL Telemedicine | 55.94M |
Aadi Bioscience | 23.82M |
Aligos Therapeutics | 7.97M |
Affimed | 7.96M |
Onconetix | 1.46M |
Lexaria Bioscience | 411.02K |
NEUE News
- 2 months ago - NeueHealth, Inc. (NEUE) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - NeueHealth Reports Second Quarter 2024 Results - Business Wire
- 3 months ago - NeueHealth to Host Second Quarter 2024 Earnings Conference Call on August 7, 2024 - Business Wire
- 3 months ago - NeueHealth Secures up to $150 Million in New Term Loan Facility with Hercules Capital - Business Wire
- 4 months ago - NeueHealth Receives NYSE Non-Compliance Letter Regarding Market Capitalization Requirements - Business Wire
- 5 months ago - NeueHealth, Inc. (NEUE) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - NeueHealth Reports First Quarter 2024 Results - Business Wire
- 6 months ago - NeueHealth to Host First Quarter 2024 Earnings Conference Call on May 8, 2024 - Business Wire